<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>China is a Threat to Biotech’s Massive Bull Run — Live Feed</title><link>https://www.live-feeds.com/feed/china-is-a-threat-to-biotech-s-massive-bull-run</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/china-is-a-threat-to-biotech-s-massive-bull-run/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>China Poses Threat to U.S. Biotech Market Growth</title><link>https://www.live-feeds.com/feed/china-is-a-threat-to-biotech-s-massive-bull-run</link><guid isPermaLink="false">https://www.live-feeds.com/feed/china-is-a-threat-to-biotech-s-massive-bull-run#u52375</guid><pubDate>Sun, 30 Aug 2026 12:00:45 +0000</pubDate><description>China is challenging the U.S. biotech sector, threatening a significant bull run in the industry. Tensions have escalated into a biotech race, prompting U.S. cities like Seattle to lobby Washington D.C. for support. While the U.S. government has introduced legislation to protect domestic biotech from Chinese competition, reports indicate a loophole exists in the bill. Some U.S. lawmakers argue that Chinese biotechnology firms are currently outperforming American companies in their ground game operations.Why it mattersThe life sciences sector is a critical area of strategic competition between </description></item>
</channel></rss>